We advance vaccines through every stage of development and create technologies and strategies to help countries deliver them.

Our Work
Articles from our global team
Related articles

Read our latest

287 Article s
  1. 16749 -  A child gets pneumococcal conjugate vaccine in Malawi. Photo: PATH/Doune Porter
    November 27, 2018

    For pneumonia and diarrhea, there's complementarity in tools and partnerships

    Strong national programs and civil society partnerships at all levels contribute to Kenya's progress against pneumonia and diarrhea.

  2. ZMSWM.jpg
    November 19, 2018

    Turning the rising malaria tide

    Malaria is on the rise. This should concern us all.

  3. A boy pumps water from a well in Zimbabwe. Photo: PATH/Jesse Schubert
    November 15, 2018

    Stemming the tide of drug-resistant typhoid in Zimbabwe

    November 12-18 is World Antibiotic Awareness Week—a time to raise awareness about the growing threat of drug resistance and our collective responsibility to safeguard the effectiveness of antibiotics through appropriate use. Drug-resistant typhoid is an urgent and growing issue that can be slowed with vaccines, which help prevent illness and the need for antibiotics in the first place. As a principle partner of the Typhoid Vaccine Acceleration Consortium, PATH is helping countries introduce typhoid conjugate vaccines (TCVs) to control outbreaks of typhoid and stem the growth of drug resistance.


    Here’s one story from Zimbabwe.

  4. Infant receives a vaccine at a national immunization clinic in The Gambia. Photo: PATH/Lauren Newhouse
    November 9, 2018

    Is the pneumonia prevention toolkit about to get bigger?

    New vaccines on the horizon, if successful, could help resource-strapped countries make valuable headway against the world’s #1 child killer—pneumonia.